Diagnostic and therapeutic implications of whole genome sequencing and phenotyping in hereditary spastic paraplegia

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Prospective cohort study investigating progression measures in patients with hereditary spastic paraplegia including clinical phenotype, severity rating scales, motor evoked potentials and diffusion tensor imaging. These measures will be correlated with genotype using whole genome sequencing and measures of economic impact from this condition.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2020

Funding Scheme: Postgraduate Scholarships

Funding Amount: $124,676.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Neurology and Neuromuscular Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

diagnostic applications | health economics | magnetic resonance imaging (MRI) | neurogenetics | phenotype-genotype correlation